Epidiolex/Epidyolex

About Jazz Pharmaceuticals

Jazz Pharmaceuticals is a global biopharmaceutical company with a mission to develop and commercialize life-changing medicines for patients with rare diseases and unmet needs. The company has achieved significant scale with a market cap of $11.32B, a portfolio of marketed products, and a robust pipeline, driven by a sharpened strategic focus on rare diseases. Its strategy combines internal R&D with disciplined business development to build a sustainable, innovative portfolio, supported by a global commercial footprint and manufacturing infrastructure.

Therapeutic Areas